Unknown

Dataset Information

0

CRISPR/Cas9-mediated knockout of APOC3 stabilizes plasma lipids and inhibits atherosclerosis in rabbits.


ABSTRACT:

Background

High levels of apolipoprotein C3 (APOC3) can lead to hypertriglyceridemia, which increases the risk of cardiovascular disease. We aim to create APOC3-knockout (KO) rabbits and explore the effects of APOC3 deletion on the occurrence and development of atherosclerosis.

Methods

An sgRNA anchored to exon 2 of APOC3 was designed to edit embryo genomes using the CRISPR/Cas9 system. The founder rabbits were sequenced, and their lipid profile, inflammatory cytokines, and atherosclerotic plaques were analyzed.

Results

When given a normal chow (NC) diet, all APOC3-KO rabbits had 50% lower triglyceride (TG) levels than those of the matched age control group. Additionally, their plasma lipoprotein lipase increased. When fed a high-fat diet, APOC3 deficiency was observed to be more conducive to the maintenance of plasma TG, total cholesterol, and low-density lipoprotein cholesterol levels, and the inhibition of the inflammatory response and the protection against atherosclerosis in rabbits.

Conclusion

APOC3 deficiency can delay the formation of atherosclerosis-induced HFD in rabbits, indicating this is a novel therapeutic target to treat atherosclerosis.

SUBMITTER: Zha Y 

PROVIDER: S-EPMC8684289 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4766569 | biostudies-literature
| S-EPMC8024976 | biostudies-literature
| S-EPMC7305219 | biostudies-literature
| S-EPMC5242459 | biostudies-literature
| S-EPMC8870212 | biostudies-literature
| S-EPMC7484272 | biostudies-literature
| S-EPMC6121927 | biostudies-literature
| S-EPMC6221038 | biostudies-literature
| S-EPMC4230364 | biostudies-literature
| S-EPMC6396427 | biostudies-literature